Borderline Resectable Pancreatic Cancer: Definitions, Management, and Role of Preoperative Therapy

Gauri R. Varadhachary(The University of Texas MD Anderson Cancer Center), Eric P. Tamm(The University of Texas MD Anderson Cancer Center), James L. Abbruzzese(The University of Texas MD Anderson Cancer Center), Henry Q. Xiong(The University of Texas MD Anderson Cancer Center), Christopher H. Crane(The University of Texas MD Anderson Cancer Center), Huamin Wang(The University of Texas MD Anderson Cancer Center), Jeffrey E. Lee(The University of Texas MD Anderson Cancer Center), Peter W. T. Pisters(The University of Texas MD Anderson Cancer Center), Douglas B. Evans(The University of Texas MD Anderson Cancer Center), Robert A. Wolff(The University of Texas MD Anderson Cancer Center)
Annals of Surgical Oncology
July 24, 2006
10.1245/aso.2006.08.011
Cited by 873

Abstract

Related Papers

Hepatogastroenterology
Liping Chen, Ning Li, Hui Ye|Hepatogastroenterology|2012|3.2k
Resected adenocarcinoma of the pancreas—616 patients: results, outcomes, and prognostic indicators
Taylor A. Sohn, Charles J. Yeo, John L. Cameron et al.|Journal of Gastrointestinal Surgery|2000|1.5k
Local staging of pancreatic cancer: criteria for unresectability of major vessels as revealed by pancreatic-phase, thin-section helical CT.
David Lu, Howard A. Reber, R M Krasny et al.|American Journal of Roentgenology|1997|547
Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas.
F R Spitz, James L. Abbruzzese, J E Lee et al.|Journal of Clinical Oncology|1997|540
Long‐term Results of Partial Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreatic Head: 25‐Year Experience
Α. Richter, Marco Niedergethmann, Jörg W. Sturm et al.|World Journal of Surgery|2003|408